By Medical News Today 12/26/2012
“Researchers at Mayo Clinic’s campus in Florida have identified an enzyme specifically linked to aggressive prostate cancer, and have also developed a compound that inhibits the ability of this molecule to promote the metastatic spread of the cancer.”
Read the entire article: http://www.medicalnewstoday.com/releases/254283.php
